Rubicon Research quarterly results

Q1 FY27 · Apr–Jun 2026

₹ crore	Q1 FY27	Year before	Change
Revenue	534	—	—
EBITDA	129	—	—
EBITDA margin	24.2%	—	—
Profit before tax	110	—	—
Net profit	84.8	—	—
EPS	₹5.13	—	—

Every quarter

₹ crore except per share

Tap a line for its trend	Q1 FY27Jun 2026	Q4 FY26Mar 2026	Q3 FY26Dec 2025	Q2 FY26Sep 2025

Expenses
	534	514	476	412
	5.7	2.6	3.8	0.7
	540	517	479	413
	154	155	184	142
	22.1	45.0	21.8	21.2
	−7.1	−30.8	−48.1	−36.8
	85.7	68.4	66.4	63.4
	9.3	10.4	9.8	11.4
	15.1	12.3	11.6	11.9
	151	158	144	128
	430	418	389	341
	129	119	108	94.3
	114	106	96.6	82.4
Profit
	110	98.7	90.6	71.7
	110	98.7	90.6	71.7
	31.6	32.4	17.7	21.2
	−6.0	−10.5	0.1	−3.3
	25.6	21.9	17.8	17.9
	84.8	76.8	72.8	53.9
	84.8	76.8	72.8	53.9
	−4.7	6.0	−3.3	−6.8
	80.0	82.7	69.5	47.1
	84.8	76.8	72.8	53.9
Per share
	₹5.13	₹4.66	₹4.46	₹3.49
	₹5.08	₹4.60	₹4.41	₹3.47
Other comprehensive income — detail
	−4.7	6.0	−3.3	−6.8
	0.1	−0.0	−0.1	−0.5
	0.0	−0.0	−0.0	−0.1
	−4.8	6.0	−3.3	−6.4
	80.0	82.7	—	—
Per share — as-filed variants
	₹5.13	₹4.66	₹4.46	₹3.49
	₹5.08	₹4.60	₹4.41	₹3.47
Derived — gross profit (revenue − materials − purchases − Δ inventories)
	365	345	318	285
	68.4%	67.1%	66.9%	69.3%
Adjusted (ex-exceptional items) — derived
	110	98.7	90.6	71.7
	84.8	76.8	72.8	53.9
	₹5.13	₹4.66	₹4.46	₹3.49

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

RUBICON₹1,425.00

Rubicon Research Ltd.

· Pharma & Health

Annual Quarterly₹ CrorePeersSHILPAMED SPARC STAR SUPRIYA PARKHOSPS THYROCARE METROPOLIS MARKSANSMcap ₹23,525 Cr

View

In ₹ Crore except Per Share 3 Months Ending	Q2 FY26 30/09/2025	Q3 FY26 31/12/2025	Q4 FY26 31/03/2026	Q1 FY27 30/06/2026
Revenue from Operations	412.0	475.5	513.9	534.3
Other Income	0.7	3.8	2.6	5.7
Total Income	412.7	479.3	516.5	540.0
Expenses
+ Cost of Materials Consumed	142.2	183.6	155.2	153.9
+ Purchases of Stock-in-Trade	21.2	21.8	45.0	22.1
+ Changes in Inventories	-36.8	-48.1	-30.8	-7.1
+ Employee Benefit Expense	63.4	66.4	68.4	85.7
+ Finance Costs	11.4	9.8	10.4	9.3
+ Depreciation & Amortisation	11.9	11.6	12.3	15.1
+ Other Expenses	127.8	143.8	157.6	150.6
Total Expenses	341.0	388.7	417.8	429.6
EBITDA	94.3	108.1	118.7	129.1
EBIT	82.4	96.6	106.4	114.0
Profit
PBT before Exceptional Items	71.7	90.6	98.7	110.4
Pretax Income	71.7	90.6	98.7	110.4
+ Current Tax	21.2	17.7	32.4	31.6
+ Deferred Tax	-3.3	0.1	-10.5	-6.0
Tax Expense	17.9	17.8	21.9	25.6
Net Income	53.9	72.8	76.8	84.8
+ Net Income — Continuing Ops	53.9	72.8	76.8	84.8
+ Other Comprehensive Income	-6.8	-3.3	6.0	-4.7
Total Comprehensive Income	47.1	69.5	82.7	80.0
Net Income to Common	53.9	72.8	76.8	84.8
Per Share
Basic EPS	3.49	4.46	4.66	5.13
Diluted EPS	3.47	4.41	4.60	5.08
Other Comprehensive Income — detail
+ Other Comprehensive Income	-6.8	-3.3	6.0	-4.7
+ Items NOT to be Reclassified to P&L	-0.5	-0.1	-0.0	0.1
+ Tax on Items NOT to be Reclassified	-0.1	-0.0	-0.0	0.0
+ Items to be Reclassified to P&L	-6.4	-3.3	6.0	-4.8
Comprehensive Income — Owners of Parent	—	—	82.7	80.0
Per Share — as-filed variants
Basic EPS — Continuing Operations	3.49	4.46	4.66	5.13
Diluted EPS — Continuing Operations	3.47	4.41	4.60	5.08
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit	285.5	318.3	344.6	365.4
Gross Margin %	69.28	66.93	67.06	68.38
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)	71.7	90.6	98.7	110.4
Net Income Adj (tax-effected)	53.9	72.8	76.8	84.8
EPS Adj	3.49	4.46	4.66	5.13
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value	1.00	1.00	1.00	1.00
Paid Up Equity Capital	15.4	16.5	16.5	16.5

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: Q1 FY27 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.

Rubicon Research Q2 FY27 results date

Rubicon Research (NSE: RUBICON) will announce its Q2 FY27 results (July–September 2026) on Thursday, 5 November 2026, according to the board-meeting notice it filed on 27 October 2026. Its latest results are for Q1 FY27 (April–June 2026). Consolidated net profit was ₹84.8 crore, up 10.4% from ₹76.8 crore in Q4 FY26. Revenue from operations was ₹534 crore, up 4.0% from the previous quarter.

Board-meeting notice filed: 27 October 2026
Q2 FY26 results (a year earlier): 13 November 2025
Q1 FY27 results (the latest): 14 August 2026

Latest results: Q1 FY27 (Apr–Jun 2026) · consolidated

Q2 FY27 results date: 5 November 2026Thursday · notice filed 27 Oct
Q1 FY27 net profit: ₹84.8 Cr+10.4% vs Q4 FY26
Q1 FY27 revenue: ₹534 Cr+4.0% vs Q4 FY26
Q1 FY27 operating margin: 21.3%+0.6 pts vs Q4 FY26
Q2 FY26 net profit (a year earlier): ₹53.9 CrRevenue ₹412 Cr
Q1 FY27 EPS (basic): ₹5.13

Questions

When will Rubicon Research announce its Q2 FY27 results?

On 5 November 2026, the date of the board meeting called to approve them (notice filed with the exchanges on 27 October 2026). Last year it reported Q2 FY26 on 13 November 2025.

What will Rubicon Research's Q2 FY27 results be compared with?

With the same quarter a year earlier, Q2 FY26 (July–September 2025), when consolidated net profit was ₹53.9 crore and revenue from operations ₹412 crore. The latest quarter, Q1 FY27, had a net profit of ₹84.8 crore and revenue of ₹534 crore.

How has Rubicon Research's profit changed over the last four quarters?

Net profit by quarter: ₹53.9 crore in Q2 FY26, ₹72.8 crore in Q3 FY26, ₹76.8 crore in Q4 FY26 and ₹84.8 crore in Q1 FY27. That is ₹288 crore over the four quarters. Revenue from operations: ₹412 crore, ₹476 crore, ₹514 crore and ₹534 crore.

What were Rubicon Research's Q1 FY27 results?

Consolidated net profit was ₹84.8 crore, up 10.4% from ₹76.8 crore in Q4 FY26. Revenue from operations was ₹534 crore, up 4.0% from the previous quarter.

What was Rubicon Research's net profit in FY26?

Consolidated net profit was ₹247 crore in FY26 (April 2025–March 2026).

What was Rubicon Research's revenue in FY26?

Revenue from operations was ₹1,754 crore in FY26 (April 2025–March 2026).

Where do these Rubicon Research figures come from?

From Rubicon Research's own consolidated results filings to NSE, in ₹ crore as filed; the date from its board-meeting notices.

Consolidated figures from the company's filings to NSE. Every company's results dates this season are in the Q2 FY27 results calendar, part of Alpha Plus.